EUROPE APHERESIS MARKET FORECAST 2021-2028

The Europe apheresis market is anticipated to project a CAGR of 8.20% over the forecast period of 2021 to 2028. The market growth of the region is primarily supplemented by the increasing numbers of apheresis procedures to treat therapeutic conditions, rising blood donation across countries, surging healthcare expenditure, and the regulations associated with the use of blood-derived products.

europe-apheresis-market

The Europe apheresis market growth assessment includes the detailed study of Poland, France, Germany, Belgium, the United Kingdom, Russia, Italy, and the rest of Europe. The market growth in the United Kingdom is fueled by the increasing incidence of chronic conditions and the surging demand for apheresis products across the country. As per the National Health Service (NHS) Blood and Transplant. Approximately 2.5 million units of blood are transfused annually, in the United Kingdom. However, several patients are infected from blood transfusions with the variant Creutzfeldt-Jakob disease (vCJD).

On the other hand, the market in Germany is evaluated to observe a growing trend, on account of the surging numbers of chronic conditions and the increasing incidence of cancer cases. Moreover, the rise in organizations that help spread awareness also plays a substantial role. Hence, these factors are set to propel the apheresis market growth in Europe over the forecasting years.

Medica SPA, headquartered in Italy, is a multinational company engaged in designing as well as manufacturing a diverse range of medical devices. The company began operations in the 1980s, providing research and development, prototyping, and manufacturing solutions to major firms, across the biomedical industry. It also produces and commercializes a wide range of medical disposables and equipment, catering to avenues such as cardiology, chronic and acute dialysis, gastroenterology, infusion, oncology, microbiological water purification, and urology.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVAILING INCIDENCE OF HEMATOLOGIC DISEASES
      2. ADVANCEMENT IN TECHNOLOGIES OF APHERESIS TECHNIQUE
      3. FAVORABLE REIMBURSEMENT POLICIES AND FUNDING FOR APHERESIS PROCEDURES
      4. GROWING GERIATRIC POPULATION
    2. KEY RESTRAINTS
      1. RISK OF BLOOD CONTAMINATION WHILE CONDUCTING TRANSFUSIONS
      2. HIGH COST OF INVESTMENT ASSOCIATED WITH APHERESIS PROCEDURES
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON APHERESIS MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYER’S POWER
      2. SUPPLIER’S POWER
      3. SUBSTITUTION
      4. NEW ENTRY
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY PROCEDURE
    1. PLASMAPHERESIS
    2. PLATELETPHERESIS
    3. LEUKAPHERESIS
    4. ERYTHROCYTAPHERESIS
    5. OTHER APHERESIS PROCEDURES
  6. MARKET BY TECHNOLOGY
    1. CENTRIFUGATION
    2. MEMBRANE SEPARATION
  7. MARKET BY PRODUCT
    1. DISPOSABLE APHERESIS KITS
    2. APHERESIS MACHINE
  8. MARKET BY APPLICATION
    1. HEMATOLOGICAL DISORDERS
    2. NEUROLOGICAL DISORDERS
    3. AUTOIMMUNE DISORDERS
    4. RENAL DISORDERS
    5. OTHER APPLICATIONS
  9. MARKET BY END-USER
    1. BLOOD BANKS/ BLOOD DONATION CENTERS
    2. HOSPITALS & CLINICS
    3. AMBULATORY SURGICAL CENTERS
  10. GEOGRAPHICAL ANALYSIS
    1. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. GERMANY
        2. FRANCE
        3. UNITED KINGDOM
        4. ITALY
        5. RUSSIA
        6. BELGIUM
        7. POLAND
        8. REST OF EUROPE
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    2. COMPANY PROFILES
      1. ASAHI KASEI CORPORATION
      2. BAXTER INTERNATIONAL INC
      3. B BRAUN MELSUNGEN AG
      4. CERUS CORPORATION
      5. CYTOSORBENTS CORPORATION
      6. FRESENIUS SE & CO KGAA (FRESENIUS KABI AG)
      7. HAEMONETICS CORPORATION
      8. HEMACARE CORPORATION
      9. INFOMED
      10. KANEKA CORPORATION
      11. KAWASUMI LABORATORIES INC
      12. MEDICAP CLINIC GMBH
      13. MEDICA SPA
      14. MILTENYI BIOTEC
      15. TERUMO CORPORATION (TERUMO BCT)
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - APHERESIS

TABLE 2: EUROPE APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: EUROPE APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: EUROPE APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: EUROPE APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: EUROPE APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: EUROPE APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: EUROPE APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: EUROPE APHERESIS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: EUROPE APHERESIS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: LEADING PLAYERS OPERATING IN EUROPE APHERESIS MARKET

TABLE 15: LIST OF MERGERS & ACQUISITIONS

TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE APHERESIS MARKET, BY PROCEDURE, IN 2020

FIGURE 6: EUROPE APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE APHERESIS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 12: EUROPE APHERESIS MARKET, BY CENTRIFUGATION, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE APHERESIS MARKET, BY PRODUCT, IN 2020

FIGURE 15: EUROPE APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE APHERESIS MARKET, BY APPLICATION, IN 2020

FIGURE 18: EUROPE APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: PREVALENCE OF BLEEDING DISORDER IN EUROPE, 2019

FIGURE 20: EUROPE APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 21: EUROPE APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 22: EUROPE APHERESIS MARKET, BY RENAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 23: EUROPE APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE APHERESIS MARKET, BY END-USER, IN 2020

FIGURE 25: EUROPE APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 26: EUROPE APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 27: EUROPE APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 28: EUROPE APHERESIS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 29: GERMANY APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: FRANCE APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: UNITED KINGDOM APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: ITALY APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: RUSSIA APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: BELGIUM APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: POLAND APHERESIS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: REST OF EUROPE APHERESIS MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample